ADMA BIOLOGICS, INC. Cash
ADMA BIOLOGICS, INC. (ADMA) had Cash of $101.24 million as of 2020-03-31, per its 10-Q filed 2020-05-06.
Discontinued › Balance Sheet › Assets › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:Cash · last filed 2020-05-06
- 2020-03-31: Cash $101.24M.
- 2019-12-31: Cash $26.75M.
- 2019-09-30: Cash $48.01M.
- 2019-06-30: Cash $73.62M.
| Period end | Cash |
|---|---|
| 2020-03-31 | $101.24M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $26.75M 10-Q · filed 2020-05-06 |
| 2019-09-30 | $48.01M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $73.62M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $16.53M 10-Q · filed 2020-05-06 |
| 2018-12-31 | $26.75M 10-Q · filed 2020-05-06 |
| 2018-09-30 | $46.37M 10-Q · filed 2019-11-06 |
| 2018-06-30 | $59.15M 10-Q · filed 2019-08-08 |
| 2018-03-31 | $31.62M 10-Q · filed 2019-05-08 |
| 2017-12-31 | $48.61M 10-Q · filed 2019-11-06 |
| 2017-09-30 | $13.60M 10-Q · filed 2018-11-09 |
| 2017-06-30 | $25.57M 10-Q · filed 2018-08-10 |
| 2017-03-31 | $8.54M 10-Q · filed 2018-05-14 |
| 2016-12-31 | $9.91M 10-Q · filed 2018-11-09 |
| 2016-09-30 | $7.91M 10-Q · filed 2017-11-03 |
| 2016-06-30 | $12.55M 10-Q · filed 2017-08-11 |
| 2016-03-31 | $8.93M 10-Q · filed 2017-05-12 |
| 2015-12-31 | $10.44M 10-Q · filed 2017-11-03 |
| 2015-09-30 | $9.18M 10-Q · filed 2016-11-10 |
| 2015-06-30 | $7.82M 10-Q · filed 2016-08-12 |
| 2015-03-31 | $16.56M 10-Q · filed 2016-05-13 |
| 2014-12-31 | $17.20M 10-Q · filed 2016-11-10 |
| 2014-09-30 | $13.95M 10-Q · filed 2015-11-10 |
| 2014-06-30 | $17.87M 10-Q · filed 2015-08-11 |
| 2014-03-31 | $26.52M 10-Q · filed 2015-05-12 |
| 2013-12-31 | $26.15M 10-Q · filed 2015-11-10 |
| 2013-09-30 | $5.38M 10-Q · filed 2014-11-10 |
| 2013-06-30 | $7.65M 10-Q · filed 2014-08-11 |
| 2013-03-31 | $10.32M 10-Q · filed 2014-05-12 |
| 2012-12-31 | $12.54M 10-Q · filed 2014-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |